148 related articles for article (PubMed ID: 10422655)
1. Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat.
Goadsby PJ; Hoskin KL
Pain; 1999 Jul; 82(1):15-22. PubMed ID: 10422655
[TBL] [Abstract][Full Text] [Related]
2. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Knight YE; Edvinsson L; Goadsby PJ
Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
[TBL] [Abstract][Full Text] [Related]
3. Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation.
Goadsby PJ; Hoskin KL; Knight YE
Neuroscience; 1998 Sep; 86(1):337-43. PubMed ID: 9692766
[TBL] [Abstract][Full Text] [Related]
4. 4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT(1B/1D) receptor agonist activity?
Knight YE; Edvinsson L; Goadsby PJ
Neuropharmacology; 2001 Mar; 40(4):520-5. PubMed ID: 11249961
[TBL] [Abstract][Full Text] [Related]
5. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
Hoskin KL; Goadsby PJ
Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
Goadsby PJ; Knight Y
Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509
[TBL] [Abstract][Full Text] [Related]
7. Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME.
Hoskin KL; Bulmer DC; Goadsby PJ
Neurosci Lett; 1999 May; 266(3):173-6. PubMed ID: 10465701
[TBL] [Abstract][Full Text] [Related]
8. Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.
Storer RJ; Goadsby PJ
Brain; 1997 Dec; 120 ( Pt 12)():2171-7. PubMed ID: 9448572
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?
Goadsby PJ; Hoskin KL
Pain; 1996 Oct; 67(2-3):355-9. PubMed ID: 8951929
[TBL] [Abstract][Full Text] [Related]
10. Effects of eletriptan on the peptidergic innervation of the cerebral dura mater and trigeminal ganglion, and on the expression of c-fos and c-jun in the trigeminal complex of the rat in an experimental migraine model.
Knyihár-Csillik E; Tajti J; Csillik AE; Chadaide Z; Mihály A; Vécsei L
Eur J Neurosci; 2000 Nov; 12(11):3991-4002. PubMed ID: 11069595
[TBL] [Abstract][Full Text] [Related]
11. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
Gupta P; Butler P; Shepperson NB; McHarg A
Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
[TBL] [Abstract][Full Text] [Related]
12. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
Martin GR
Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012
[TBL] [Abstract][Full Text] [Related]
14. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
Goadsby PJ; Hoskin KL
Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
[TBL] [Abstract][Full Text] [Related]
15. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges.
Nozaki K; Moskowitz MA; Boccalini P
Br J Pharmacol; 1992 Jun; 106(2):409-15. PubMed ID: 1327382
[TBL] [Abstract][Full Text] [Related]
16. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism.
Hoskin KL; Kaube H; Goadsby PJ
Brain; 1996 Oct; 119 ( Pt 5)():1419-28. PubMed ID: 8931567
[TBL] [Abstract][Full Text] [Related]
17. The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat.
Hoskin KL; Lambert GA; Donaldson C; Zagami AS
Brain Res; 2004 Feb; 998(1):91-9. PubMed ID: 14725972
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine(1B/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis.
Mitsikostas DD; Sanchez del Rio M; Waeber C
Cephalalgia; 2002 Jun; 22(5):384-94. PubMed ID: 12110114
[TBL] [Abstract][Full Text] [Related]
19. The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.
Gupta P; Brown D; Butler P; Ellis P; Grayson KL; Land GC; Macor JE; Robson SF; Wythes MJ; Shepperson NB
Br J Pharmacol; 1995 Nov; 116(5):2385-90. PubMed ID: 8581273
[TBL] [Abstract][Full Text] [Related]
20. Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin.
Cutrer FM; Schoenfeld D; Limmroth V; Panahian N; Moskowitz MA
Br J Pharmacol; 1995 Mar; 114(5):987-92. PubMed ID: 7780655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
